Skip to main content
Latest news
Browse specialties
Breast cancer Genitourinary cancers Lung & thoracic cancers
In focus
Next-generation sequencing: Emerging biomarkers in thyroid and NSCLCs ctDNA and bladder cancer: Current understanding and beyond ROS1 fusion-positive NSCLC NSCLC driver mutations: Discussing the importance of RET, ALK and ROS1 alterations in NSCLC Early-stage NSCLC management: Surgery, targeted treatment and immunotherapy ALK fusion-positive NSCLC: International approaches to management RET fusion-positive NSCLC: Informing on the use of pralsetinib for patients with RET fusion-positive, advanced NSCLC COVID-19 & cancer
Conferences
SABCS 2022 ESMO 2022 2022 ASCO Annual Meeting
About us
Medicine Matters Oncology
EXTENDED SEARCH

Medicine Matters oncology

Grosshansdorf, Germany

Professor Reck undertook his medical training at The University of Hamburg, Germany, from 1986 to 1993. He completed his doctorate at the General Hospital Wandsbek, Hamburg, in 1995 and received post-graduate training at the Hospital Grosshansdorf, Germany. In 2001 he was appointed as a specialist in internal medicine and in 2002 he was also appointed as a specialist in pulmonology. In 2008 he was awarded a post-doctoral lecturing qualification by the University of Schleswig-Holstein, Germany.

Professor Reck has been a Principal Investigator (PI) or Co-PI in various clinical trials since 1993. His main interests are targeted therapies in non-small-cell lung cancer, new approaches in small-cell lung cancer and modern therapies in malignant pleural mesothelioma, as well as translational research related to predictive markers. He has been involved in several key trials investigating new treatment approaches in the treatment of advanced stage of disease such as, maintenance treatment or treatment with targeted therapies, as well as key biomarker trials.

He is Head of the Department of Thoracic Oncology as well as Head of the Clinical Trial Department in the Department of Thoracic Oncology at the Lung Clinic Grosshansdorf. Furthermore he is PI in the German centre for lung research (DZL) in the area of lung cancer.

Martin Reck is a member of: the German Working Group for Lung Cancer, the German Cancer Society, the German Society of Pulmonology, the International Association for the Study of Lung Cancer, the European Society for Medical Oncology (ESMO) and the American Society of Clinical Oncology (ASCO).